Logotype for Embla Medical

Embla Medical (EMBLA) CMD 2023 summary

Event summary combining transcript, slides, and related documents.

Logotype for Embla Medical

CMD 2023 summary

3 Mar, 2026

Strategic direction and Growth'27 plan

  • Launched Growth'27, a five-year strategy focused on expanding patient reach, innovative solutions, and O&P value creation, aiming for accelerated organic growth and increased transparency.

  • Continued commitment to Bracing Simplified for injury care, emphasizing customer partnerships and streamlined product offerings.

  • Acquisitions will supplement organic growth, with a focus on market access, portfolio expansion, and technology.

  • Sustainability, people, and scalability remain foundational pillars, with enhanced reporting and segmentation.

  • New sales segmentation introduced to better reflect the evolving business mix and provide improved transparency.

Market position and business developments

  • Holds strong positions in prosthetics (#2 globally), bracing & supports (#4), and patient care (#3), with significant growth opportunities in emerging and developed markets.

  • Shifted business mix toward chronic mobility solutions, with divestments in non-core areas and acquisitions in patient care and prosthetics.

  • Direct presence expanded to 17 emerging and 22 developed markets, with 90% of sales from developed markets.

  • Majority of O&P channel patients have lifelong chronic mobility challenges, driving recurring sales and service needs.

  • Enhanced patient reach through new care models, digital engagement, and functional trade-up strategies in both developed and emerging markets.

Innovation and product development

  • Innovation strategy centers on patient-centric solutions with proven clinical efficacy, focusing on prosthetics and chronic mobility challenges.

  • Recent innovations include advanced socket solutions, increased bionic penetration, and AeroFit® breathable liners to address clinical challenges.

  • Ongoing R&D investment outpaces sales growth, with a robust pipeline targeting higher fitting rates and functional upgrades.

  • Future efforts include AI, machine learning, and mind-controlled prosthetics, as well as wearable robotics for stroke rehabilitation.

  • Preparing for data-driven, customized healthcare solutions and expanding into new chronic categories.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more